Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05115331 · ClinicalTrials.gov registry record · Phase 3
Palliative UNConventional Hypofractionation Trial for Metastatic Bone Disease
A Phase 3 study of Metastatic Bone Tumor, sponsored by University of Cincinnati.
- Active
- Registry status
- Phase 3
- Development phase
- 168
- Enrollment target
- 1
- Study location
NCT05115331 is a Phase 3 study of Metastatic Bone Tumor that is active but no longer recruiting, run by University of Cincinnati. The registered enrollment target is 168 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05115331, a Phase 3 study of Metastatic Bone Tumor, is active but no longer recruiting, sponsored by University of Cincinnati.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 3
- Development phase
- 168 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a randomized Phase III study evaluating the efficacy of hypofractionated and dose-escalated palliative radiation therapy in metastatic bone disease (MBD). Patients will be randomized 1:1 to the conventional (8 Gy in a single fraction) and experimental (16 Gy in 2 fractions) groups with baseline and subsequent assessment of both pain and quality of life metrics.
Conditions Studied
Interventions
- RADIATION Experimental Radiation Dose
- RADIATION Conventional Radiation Dose
Study Locations (1)
Ohio
- University of Cincinnati - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 168 participants |
| Start Date | 2021-11-24 |
| Est. Completion | 2025-11-24 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05115331
The ClinicalTrials.gov registry entry for NCT05115331 describes a study currently listed as active not recruiting, categorized as Phase 3. The registered enrollment target is 168 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Cincinnati, which has 245 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Metastatic Bone Tumor appearing as the primary indexed condition, and to 2 interventions - of which Experimental Radiation Dose is the first listed.
NCT05115331 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT05115331 about?
NCT05115331 is a clinical study titled "Palliative UNConventional Hypofractionation Trial for Metastatic Bone Disease". This is a randomized Phase III study evaluating the efficacy of hypofractionated and dose-escalated palliative radiation therapy in metastatic bone disease (MBD). Patients will be randomized 1:1 to the conventional (8 Gy in a single fraction) and experimental (16 Gy in 2 fractions) groups with basel...
What is the current status of trial NCT05115331?
This trial is currently active not recruiting. It is a Phase 3 study. The enrollment target is 168 participants. The study started on 2021-11-24. Estimated completion is 2025-11-24.
What conditions does trial NCT05115331 study?
This clinical trial studies the following conditions: Metastatic Bone Tumor.
What interventions are being tested in trial NCT05115331?
The interventions under investigation include: Experimental Radiation Dose (RADIATION), Conventional Radiation Dose (RADIATION).
Who is sponsoring clinical trial NCT05115331?
This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05115331 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Metastatic Bone Tumor
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.